The Dividend Aristocrats Ranked By Quality Scores (October 2026)

The author ranks all 69 S&P 500 Dividend Aristocrats using 9F Quality Scores and consensus fair-value estimates based on up to 40 data points per stock. The analysis identifies 12 as undervalued, 18 as fairly valued, and 39 as overvalued, and names candidates by investment style, including ADP, BRO, and NDSN for growth; NEE for total return; PEP and O for income; and CAT and GWW for past performance.

Analysis

This is a valuation screen, not a near-term catalyst: without the underlying fair-value estimates, assumptions, or current prices, the 12/18/39 split cannot establish that the named stocks offer attractive risk-adjusted returns. The key portfolio implication is factor exposure. O and NEE are particularly sensitive to real yields and financing conditions; PEP is more defensive, while CAT and GWW carry greater sensitivity to industrial demand. Treating all as interchangeable “Aristocrats” risks hiding that duration and cyclical mix. If investors act on the growth shortlist (ADP, BRO, NDSN), multiple expansion could dominate near-term returns, so a quality label alone is not protection against valuation compression. The contrarian point is that a broad overvaluation count may reflect the model’s assumptions rather than an imminent market-wide reversal; absent methodology and company-level valuation gaps, this is weak evidence for shorting the cohort. Immediate impact should be limited. Over 1–3 months, watch earnings, guidance, real yields, and whether the author’s estimates are updated; over 6–18 months, dividend growth and reinvestment returns matter more than the ranking. Falsify any valuation-led thesis with sustained estimate revisions in the opposite direction or a material change in real rates that reprices the relevant duration exposures.

Key Decisions for Investors

• Do not trade the aggregate “overvalued” count or buy the growth shortlist on this article alone. First verify the fair-value methodology, valuation discount/premium by name, assumed growth and discount rates, and date of the price inputs.
• Use O and NEE as a rates-sensitivity watchlist, not an automatic pair: consider adding only if real yields fall and company guidance supports the thesis; reassess if real yields rise materially or financing/capital plans weaken.
• For ADP, BRO, and NDSN, require earnings and guidance confirmation before adding. A sustained deterioration in organic growth or margin outlook would falsify a quality-growth thesis; absent that, no short is warranted solely from the ranking.
• Keep CAT and GWW exposure tied to industrial-demand indicators and estimate revisions rather than past performance. Reduce or avoid adding if order/demand signals weaken; the article provides no evidence of a current cyclical inflection.
• PEP may serve as a defensive-income watch item, but verify volume, pricing, and earnings trends before treating its dividend profile as downside protection. No clear standalone trade is supported by the supplied information.